Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-18 Sale |
2024-06-21 6:00 pm |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $75.91 | $1,518,199 | 9,690 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 8:33 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
61,277 | $66.07 | $4,048,400 | 1,070,875 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 8:33 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
23,253 | $66.32 | $1,542,147 | 10,121 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 8:32 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
20,477 | $66.09 | $1,353,235 | 7,345 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 8:31 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
20,477 | $66.23 | $1,356,110 | 37,045 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 8:31 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
10,162 | $66.21 | $672,791 | 27,148 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-28 7:41 pm |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $72.93 | $1,458,650 | 9,611 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 8:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,907 | $69.53 | $549,784 | 0 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 8:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
13,337 | $69.43 | $925,961 | 0 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 7:59 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
22,590 | $69.79 | $1,576,464 | 1,050,309 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 7:58 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
4,112 | $70.17 | $288,534 | 9,488 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 7:58 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,907 | $70.13 | $554,491 | 29,700 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 7:57 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
26,328 | $68.68 | $1,808,253 | 49,662 (Indirect Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 6:13 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,860 | $66.42 | $787,719 | 0 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 6:10 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
33,885 | $67.07 | $2,272,694 | 1,050,309 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 6:07 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
11,860 | $67.15 | $796,367 | 29,700 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 6:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
11,183 | $66.62 | $745,037 | 0 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 6:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
6,167 | $67.19 | $414,355 | 5,693 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 7:47 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
191,362 | $66.27 | $12,680,892 | 1,260,141 (Direct) |
View |
| 2024-01-11 Sale |
2024-01-12 6:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
50,000 | $66.83 | $3,341,699 | 22,869 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 7:54 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
62,282 | $70.6 | $4,397,113 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-18 Exercise |
2024-06-21 6:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $16.86 | 9,690 (Direct) |
View |
| 2024-06-18 Exercise |
2024-06-21 6:00 pm |
N/A 2024-06-30 |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $0 | 9,690 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 6:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director |
7,273 | $0 | 7,273 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 6:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
7,273 | $0 | 7,273 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
7,273 | $0 | 7,273 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 6:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
7,273 | $0 | 7,273 (Direct) |
View |
| 2024-04-24 Exercise |
2024-04-25 5:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
8,638 | $16.86 | 1,287,327 (Direct) |
View |
| 2024-04-24 Exercise |
2024-04-25 5:08 pm |
N/A 2024-06-30 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
20,020 | $0 | 1,287,327 (Direct) |
View |
| 2024-04-24 Exercise |
2024-04-25 5:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO |
11,382 | $17.57 | 1,287,327 (Direct) |
View |
| 2024-03-31 Option Award |
2024-04-02 4:15 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
79 | $69.2 | 9,690 (Direct) |
View |
| 2024-03-31 Option Award |
2024-04-02 4:15 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
260 | $69.2 | 99,495 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 4:12 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
20,000 | $18.56 | 99,235 (Direct) |
View |
| 2024-03-20 Exercise |
2024-03-22 4:12 pm |
N/A 2024-03-21 |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
20,000 | $0 | 99,235 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 8:33 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
20,565 | $0 | 1,070,875 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 8:33 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
4,539 | $56.73 | 10,121 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 8:33 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
10,121 | $0 | 10,121 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 8:32 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,345 | $0 | 7,345 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 8:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,345 | $0 | 37,045 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 8:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
7,345 | $0 | 27,148 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 5:59 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
13,132 | $0 | 69,098 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 5:59 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
40,712 | $0 | 1,172,446 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 5:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
13,132 | $0 | 39,398 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 5:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
13,132 | $0 | 39,398 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 5:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
13,132 | $0 | 48,886 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
36,717 | $0 | 36,717 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
26,227 | $0 | 26,227 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
26,227 | $0 | 26,227 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
26,227 | $0 | 26,227 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 7:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
104,909 | $0 | 104,909 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-28 7:41 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $18.56 | 9,611 (Direct) |
View |
| 2024-02-27 Exercise |
2024-02-28 7:41 pm |
N/A 2024-03-21 |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $0 | 9,611 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 8:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
7,907 | $0 | 0 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-27 8:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
5,882 | $36.89 | 0 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 8:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
13,337 | $0 | 0 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 7:59 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
22,590 | $0 | 1,050,309 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 7:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
7,907 | $0 | 9,488 (Direct) |
View |
| 2024-02-23 Exercise |
2024-02-27 7:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
7,907 | $0 | 29,700 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-27 7:57 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
16,757 | $55.48 | 49,662 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-27 7:57 pm |
N/A 2031-06-20 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
36,757 | $0 | 49,662 (Direct) |
View |
| 2024-02-26 Exercise |
2024-02-27 7:57 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $43.45 | 49,662 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 6:13 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,860 | $0 | 0 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 6:10 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
33,885 | $0 | 1,050,309 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 6:07 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
11,860 | $0 | 29,700 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 6:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO |
11,183 | $0 | 0 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 6:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
11,860 | $0 | 5,693 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 7:47 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
191,362 | $16.86 | 1,260,141 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 7:47 pm |
N/A 2024-06-30 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
191,362 | $0 | 1,260,141 (Direct) |
View |
| 2024-01-11 Exercise |
2024-01-12 6:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
46,115 | $12.73 | 22,869 (Direct) |
View |
| 2024-01-11 Exercise |
2024-01-12 6:02 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
50,000 | $0 | 22,869 (Direct) |
View |
| 2024-01-11 Exercise |
2024-01-12 6:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
3,885 | $23.94 | 22,869 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 7:54 pm |
N/A 2028-08-15 |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
62,282 | $0 | 0 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-04 7:54 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer |
62,282 | $19.87 | 0 (Direct) |
View |
| 2023-12-31 Option Award |
2024-01-03 6:46 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
251 | $71.62 | 79,235 (Direct) |
View |